DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests

PRESS RELEASESLeave a comment

DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests   Both biotechnology firms have signed a cross-licensing agreement to share technology to develop RNA quantification tests directly from biological samples. Initial tests will focus both on RNA biomarkers for drug-induced hepatotoxicity, nephrotoxicity and cardiotoxicity, and on therapeutic RNAs.  Thanks to the combination…